Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001902368-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
2,476
Total Value
$98,404.33
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Jan 5, 2026 | Sale | 2,031 | $40.18 | $81,605.58 | 86,756 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Jan 6, 2026 | Sale | 445 | $37.75 | $16,798.75 | 86,311 | Direct | โ | View Details |